Market Research Report
Implantable Drug Delivery Devices Market by Material, Product Type and End User : Global Opportunity Analysis and Industry Forecast, 2019-2027
|Published by||Allied Market Research||Product code||975074|
|Published||Content info||219 Pages
Delivery time: 2-3 business days
|Implantable Drug Delivery Devices Market by Material, Product Type and End User : Global Opportunity Analysis and Industry Forecast, 2019-2027|
|Published: October 31, 2020||Content info: 219 Pages||
Implantable Drug Delivery Devices Market by Material (Silicon and Others), Product Type (Implantable Drug Eluting Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Brachytherapy Seeds Devices, and Implantable Drug Delivery Pump Devices) and End User (Hospitals, Ambulatory Surgery Center, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027.
The global implantable drug delivery devices market was valued at $10,091.9 million in 2019, and is projected to reach $13,211.8 million by 2027 at a CAGR of 8.0% from 2020 to 2027.
Implantable drug delivery devices consist of a drug reservoir surrounded by a polymer or a drug polymer mixture. When inserted into a desired area in the body, the drug is released at a pre-determined rate as the polymer degrades. Implantable drug delivery devices offer a number of advantages over conventional oral or parenteral dosage forms. It allows site specific drug administration where a drug is most needed.
This allows significant lower doses of drugs, which minimize potential side effects. Furthermore, implantable devices allow for sustained release of a therapeutic agent. In addition, treatment schedule associated with an implantable device is generally less burdensome than pills or injections.
Growth of the implantable drug delivery devices market is driven by rise in prevalence of chronic diseases across the globe, increase in demand for minimally invasive drug delivery devices, and unwanted pregnancies over a period. However, possibility of implanted device failures, and stringent government regulations impede the market growth. Conversely, collaboration activities among leading market players are expected to provide lucrative growth opportunities for the market.
The implantable drug delivery devices market is segmented into material, product type, end user, and region. By material, the market is divided into silicon and others. On the basis of product type, implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Product Type
By End User